Seed IP partners, Chandra E. Eidt and Jeffrey C. Pepe, Ph.D., are moderating a panel at the upcoming BIO IP Counsels Committee (BIO-IPCC) conference, taking place April 8-10 in Denver, Colorado. The panel, sponsored by Seed IP Law Group, is entitled, “Biosimilars: Where are we now and where are we going?,” and is set for Wednesday, April 10 from 8:30-9:45 a.m. This panel will discuss the evolving landscape of US and EP biosimilar approvals and patent considerations. Also to be discussed are biosimilar patent prosecution and litigation strategies, as well as risk assessment and management for developing biosimilars.
Speakers on this panel are:
Michael W. Johnson, Partner, Willkie Farr & Gallagher LLP
Gonzalo Merino, Ph.D., J.D., Vice President, Chief Intellectual Property Counsel, Regeneron Pharmaceuticals, Inc.
Dr. Leonard L. Werner-Jones, Partner, European Patent Attorney, Hoffmann Eitle
Official website and agenda for BIO-IPCC
Read more about Chandra E. Eidt
Read more about Jeffrey C. Pepe, Ph.D.